Committee News Release:

Committee News

The House Committee on Energy and Commerce

W.J. "Billy" Tauzin, Chairman

Link to Committee Tip Line: Fight Waste, Fraud and Abuse

Greenwood Seeks Clinical Trial Data on Antidepressants

Contact: Ken Johnson (202.225.5735)

WASHINGTON (February 3) - As part of its ongoing investigation into the safety of prescription drugs, Rep. James Greenwood (R-PA), Chairman of the House Energy and Commerce Subcommittee on Oversight and Investigations, sent letters to four drug manufacturers seeking data and background information on unpublished clinical trials involving depressed children.

Identical letters were sent February 3 to:

Wyeth Pharmaceuticals President Bernard Poussot,

Eli Lilly & Company Chairman Sidney Taurel;

GlaxoSmithKline President Christopher Viehbacher; and,

Pfizer Chairman and CEO Dr. Hank McKinnell, Ph.D.)

####

Related Documents

Greenwood Seeks Clinical Trial Data on Antidepressants
Letter to Dr. Hank A. McKinnell
Pfizer Inc.
February 3, 2004

Greenwood Seeks Clinical Trial Data on Antidepressants
Letter to Mr. Christopher Viehbacher
GlaxoSmithKline
February 3, 2004

Greenwood Seeks Clinical Trial Data on Antidepressants
Letter to Mr. Sidney Taurel
Eli Lilly & Company
March 2, 2004

News Release
Greenwood Expands Investigation Into Questionable NIH Practices
February 4, 2004

Greenwood Expands Investigation Into Questionable NIH Practices
Letter to The Honorable Tommy Thompson
U.S. Department of Health and Human Services
February 4, 2004

News Release
Greenwood Requests GAO Review Of State Medicaid Rebate Programs
February 4, 2004

Greenwood Requests GAO Review Of State Medicaid Rebate Programs
Letter to Mr. David M. Walker
General Accounting Office
February 4, 2004